OR WAIT null SECS
February 12, 2025
Acoramidis was approved by FDA in November 2024 and is prescribed in the US under the brand name Attruby.
Pharmaceutical Technology® sat down with Jean Redmond, Chief Operating Officer at Biologit, to discuss the use of artificial intelligence in pharmaceutical research and development and the role women play in this fast-developing area.
February 11, 2025
The company says it is the pharmaceutical market’s first wet granulator with an integrated, truly continuous dryer.
While this approval addresses breast cancer, olaparib in combination with durvalumab was approved by the EU in August 2024 for treatment of endometrial cancer.
Feb. 11, 2025 marks the 10th anniversary of the International Day of Women and Girls in Science.
In a lead up to The International Day of Women and Girls in Science, Pharmaceutical Technology® takes a look at the unique perspective women bring to the use of artificial intelligence in the pharmaceutical industry.
February 10, 2025
These infections can be caused by certain Gram-negative microorganisms, making the infections challenging to control due to high antimicrobial resistance.
Experts provide their insights into the trends that have shaped the global bio/pharma industry in 2024 and give their predictions as to what may be impactful in 2025 and beyond.
Pharmaceutical Technology® sat down with Michelle Bridenbaker, COO of Unbiased Science, ahead of International Day of Women and Girls in Science to talk about the role of women in the pharmaceutical industry.
Pharmaceutical Technology® sat down with Kate Coleman from Arriello to run through the major trends from 2024, including the importance of technological advances, and how these may progress in 2025.